Admission Date:  [**2122-4-21**]              Discharge Date:   [**2122-4-29**]  Date of Birth:  [**2056-4-20**]             Sex:   F  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 34120**] Chief Complaint: nausea, vomiting, fatigue, abdominal distention   Major Surgical or Invasive Procedure: Paracentesis [**2122-4-22**] Central line placement [**2122-4-21**] PICC line placement [**2122-4-24**]   History of Present Illness: This is a 65 year-old Female with a PMH significant for poorly differentiated metastatic adenocarcinoma of unknown primary with neuroendocrine features (diagnosed in [**12/2120**] s/p 4-cycles of chemotherapy with most recent administration of cisplatin and etoposide on [**2122-4-15**]; recent PET-CT imaging showing overall disease progression), vitamin B12 deficiency, hypertension, hyperlipidemia, rosacea and reflux esophagitis who presents with several days of fatigue in the setting of nausea, emesis and poor PO intake.
Her weight was also noted to up 5-lbs from baseline (weight from [**2122-3-19**] 62.1 kg, [**2122-4-9**] 66.0 kg).
On arrival to the [**Hospital1 18**] ED, initial VS 99.5 103 112/45 16 99% RA.
Her laboratory studies were notable for WBC 0.1 (36% neutrophils, ANC 36), HCT 23.6%, PLT 132.
Serum chemistry revealed sodium 132, potassium 2.7, BUN 40, creatinine 1.5 (baseline 0.8).
INR 1.0.
Troponin < 0.01.
LFTs: AST 45, ALT 30, AP 307, T-bili 0.8, Alb 2.6.
A CXR showed no evidence of consolidation.
Prior to transfer, VS 98.3 107 106/67.
EGD ([**2120-12-20**]) demonstrated gastritis that was H.pylori positive.
CT imaging in [**12/2120**] revealed inumerable liver metastases and omentum cake with marked ascites and small left adrenal mass.
Biopsy of a liver lesion noted poorly differentiated carcinoma with neuroendocrine features (strongly positive for CK7, TTF-1, synpatophysin and focal positivity for chromogranin and [**Last Name (un) **]-31, but CK-20, CDX-2, S100 negative.
The immunohistochemical profile fit lung carcinoma, but CT chest imaging revealed multiple small pulmonary nodules without dominant lung mass.
In [**1-/2121**] she had large volume paracentesis and underwent initiation of chemotherapy ([**2121-1-15**]) - Carboplatin AUC 5 and Paclitaxol (therapy from [**2121-1-15**] to [**2121-5-1**] for 4-cycles) - Carboplatin and Doxil (for widespread recurrence, [**2121-9-4**] to [**2121-11-6**] for 3-cycles) - Gemcitabine and Docetaxol (for disease progression, [**2121-12-4**] to [**2122-4-2**] for 6-cycles) - Cisplatin and Etoposide (began cycling on [**2122-4-13**], last dosing [**2122-4-15**]) .
Neuropathy (from chemotherapy) 6.
Reflux esophagitis, GERD (EGD negative in [**2115**] showing gastritis)  Social History: The patient is never married.
DISCHARGE EXAM: VS- Tm/c 97.6 BO 106/56 HR 104 RR 16 O2 98% RA I/O- 1080/2050 Gen- pale, cachectic female in NAD HEENT- sclera anicteric, PERRL, EOMI, moist mucous membranes without erythema, exudate or lesions Neck- no palpable lymphadenopathy CV- RRR, normal S1/S2, no m/r/g Pulm- CTA, decreased breath sounds at bilateral bases, no wheezes, ronchi or rales Abd- +BS, soft, nontender, +tympany, no heptosplenomegaly palpable, no rebound/guarding Ext- WWP, 2+ edema to knees bilaterally, 2+ DP/PT pulses Neuro- A+Ox 3, CN intact, strength 5/5 bilaterally in upper and lower extremities Access- Site of prior R IJ c/d/i, PICC site c/d/i   Pertinent Results: Lab Results on Admission: WBC-0.1*# RBC-2.54*# Hgb-8.3*# Hct-23.6*# MCV-93 MCH-32.6* MCHC-35.0 RDW-16.6* Plt Ct-132*# Neuts-36* Bands-0 Lymphs-64* Monos-0 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 Hypochr-NORMAL Anisocy-1+ Poiklo-1+ Macrocy-1+ Microcy-OCCASIONAL Polychr-NORMAL Ovalocy-OCCASIONAL Tear Dr[**Last Name (STitle) 833**] Plt Smr-LOW Plt Ct-132*# PT-11.1 PTT-22.7* INR(PT)-1.0 Fibrino-507*# FDP-10-40* Glucose-130* UreaN-40* Creat-1.5* Na-132* K-2.7* Cl-88* HCO3-29 AnGap-18 ALT-30 AST-45* AlkPhos-307* TotBili-0.8 LD(LDH)-842* Lipase-17 cTropnT-<0.01 Albumin-2.6* Calcium-8.4 Phos-3.4 Mg-1.6 Hapto-335* [**2122-4-21**] 11:39AM BLOOD Lactate-1.8 [**2122-4-21**] 08:19PM BLOOD Lactate-0.8 [**2122-4-21**] 08:19PM BLOOD O2 Sat-78 [**2122-4-21**] 08:19PM BLOOD freeCa-1.02*  URINE Color-Yellow Appear-Clear Sp [**Last Name (un) **]-1.009 Blood-NEG Nitrite-NEG Protein-30 Glucose-70 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG RBC-1 WBC-1 Bacteri-FEW Yeast-NONE Epi-0 UreaN-510 Creat-43 Na-27 K-37 Cl-56 Osmolal-381 .
Labs on discharge: WBC-15.3* RBC-3.03* Hgb-8.8* Hct-28.3* MCV-93 MCH-29.2 MCHC-31.2 RDW-16.8* Plt Ct-88*# Neuts-72* Bands-2 Lymphs-9* Monos-11 Eos-0 Baso-1 Atyps-2* Metas-0 Myelos-1* Promyel-2* Glucose-90 UreaN-17 Creat-1.0 Na-135 K-3.0* Cl-99 HCO3-29 AnGap-10 Calcium-7.8* Phos-2.9 Mg-1.5* .
SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________                              KLEBSIELLA OXYTOCA                              | AMPICILLIN/SULBACTAM--   <=2 S CEFAZOLIN-------------   <=4 S CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO-----       S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----   <=1 S    Anaerobic Bottle Gram Stain (Final [**2122-4-22**]): GRAM NEGATIVE ROD(S)  [**4-21**] Blood Culture       STREPTOCOCCUS INFANTARIUS SSP.
SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________                              STREPTOCOCCUS                              |          ESCHERICHIA COLI                              |          | AMPICILLIN------------                4 S AMPICILLIN/SULBACTAM--              <=2 S CEFAZOLIN-------------              <=4 S CEFEPIME--------------              <=1 S CEFTAZIDIME-----------              <=1 S CEFTRIAXONE-----------              <=1 S CIPROFLOXACIN---------           <=0.25 S CLINDAMYCIN-----------       S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------              <=1 S MEROPENEM-------------           <=0.25 S PENICILLIN G----------<=0.06 S PIPERACILLIN/TAZO-----                  S TOBRAMYCIN------------              <=1 S TRIMETHOPRIM/SULFA----              <=1 S VANCOMYCIN------------   <=1 S     Aerobic Bottle Gram Stain (Final [**2122-4-22**]):       GRAM POSITIVE COCCI IN PAIRS AND IN SHORT CHAINS.
Anaerobic Bottle Gram Stain (Final [**2122-4-22**]):       GRAM NEGATIVE ROD(S).
[**2122-4-6**] FDG TUMOR IMAGING (PET-CT) - Significant progression of disease burden since the examination from [**2122-1-28**] with worsening peritoneal carcinomatosis, ascites, liver metastases, and pulmonary nodules.
[**2122-4-10**] PARACENTESIS DIAG/THERA - Uncomplicated ultrasound-guided therapeutic and diagnostic paracentesis, with removal of 4.0 liters of serosanguinous ascites.
[**2122-4-21**] CHEST (PA & LAT) - The lungs are clear.
Cardiac silhouette is within normal limits.
[**2122-4-21**] CT ABD & PELVIS W/O CON - Large ascites with layering dependent hematocrit level consistent with hemoperitoneum.
Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%).
Several air-fluid levels noted in the colon.
She was broadly covered, then narrowed to vancomycin/ceftriaxone once cultures grew pansensitive klebsiella and streptococcus.
A 2D-Echo was negative for valvular vegetations.
# ACUTE RENAL INSUFFICIENCY, METABOLIC DERANGEMENTS - Patient presented with acute elevation in creatinine to 1.5 with BUN 40 in the setting of septic shock.
Following volume resuscitation, patient's creatinine returned to baseline (0.8-1.1) and remained there for the rest of hospitalization.
# LEUKOPENIA, ACUTE ON CHRONIC NORMOCYTIC ANEMIA, THROMBOCYTOPENIA - Patient required PRBC and platelet transfusions during admission secondary to myelosuppressive therapy.
Blood pressure well controlled throughout admission.
Your blood counts improved with time and an injection that stimulated your bone marrow.
